Are Nath Bio-Genes latest results good or bad?
Nath Bio-Genes' latest results are generally positive, with net sales growing 16.33% year-on-year and improved profitability indicators; however, rising interest expenses may present a challenge moving forward.
Nath Bio-Genes (India) has reported its financial results for the quarter ending June 2025, revealing several noteworthy trends. The company's net sales reached Rs 283.70 crore, representing a year-on-year growth of 16.33%, which is a significant improvement compared to the previous year. The operating profit (PBDIT) also showed a positive trend, peaking at Rs 38.29 crore, while the profit before tax (PBT) was recorded at Rs 34.12 crore. Profit after tax (PAT) amounted to Rs 37.28 crore, and earnings per share (EPS) rose to Rs 19.62, indicating enhanced profitability for shareholders.Additionally, the debtors turnover ratio improved to 4.10 times, suggesting that the company has been effective in managing its receivables. However, it is important to note that interest expenses rose sharply to Rs 3.20 crore, reflecting a significant increase quarter on quarter, which may indicate higher borrowing costs for the company.
Overall, while Nath Bio-Genes has demonstrated strong operational performance in several key areas, the rise in interest expenses could pose a challenge. Furthermore, the company saw an adjustment in its evaluation over the last three months, reflecting changes in its financial standing.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
